LEVOFLOXACIN NEBULISER SOLUTION (Quinsair®)

Clinical Indication

Chronic Pseudomonas lung infection in cystic fibrosis (adults)

Date of classification

June 2016

Review date

June 2019

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).